Ronald M. Goldenberg, Christine Ibrahim, Jill Trinacty. Glucagon‐Like Peptide‐1 Medicines and Risk of Dysaesthesia: A Systematic Review, Meta‐Analysis and Meta‐Regression of Randomised Controlled Trials. // Diabetes, Obesity and Metabolism. – 2026. – DOI: 10.1111/dom.71331. – URL: https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.71331?af=R
Ronald M. Goldenberg, Christine Ibrahim, & Jill Trinacty (2026). Glucagon‐Like Peptide‐1 Medicines and Risk of Dysaesthesia: A Systematic Review, Meta‐Analysis and Meta‐Regression of Randomised Controlled Trials. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71331
Ronald M. Goldenberg, et al. “Glucagon‐Like Peptide‐1 Medicines and Risk of Dysaesthesia: A Systematic Review, Meta‐Analysis and Meta‐Regression of Randomised Controlled Trials.” Diabetes, Obesity and Metabolism, 2026. doi:10.1111/dom.71331.
@article{Goldenberg2026,
title = {Glucagon‐Like Peptide‐1 Medicines and Risk of Dysaesthesia: A Systematic Review, Meta‐Analysis and Meta‐Regression of Randomised Controlled Trials},
author = {Goldenberg, Ronald M. and Ibrahim, Christine and Trinacty, Jill},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71331},
url = {https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.71331?af=R}
}